A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

Phoenix

Tucson

Little Rock

Los Angeles

Martinez

Santa Barbara

Torrance

Upland

Denver

Norwich

Gainesville

Miami

Miami Shores

New Port Richey

Atlanta

Evanston

Joliet

Peoria

Rockford

Skokie

Urbana

Anderson

Cedar Rapids

Brewer

Baltimore

Silver Spring

Boston

Detroit

Rochester

Saint Cloud

Kansas City

Grand Island

Las Vegas

Lebanon

Albany

East Syracuse

New York

Rochester

The Bronx

Charlotte

High Point

Cleveland

Eugene

Portland

Erie

Charleston

Greenville

North Charleston

Rapid City

Nashville

Abilene

Austin

Beaumont

Bedford

Dallas

Denton

Flower Mound

Garland

Houston

Paris

San Antonio

Sugar Land

Temple

The Woodlands

Tyler

Waco

Roanoke

Winchester

Green Bay

Weston

Amberloup

Bonheiden

Brussels

Edegem

Laken (brussel)

Turnhout

Wilrijk

Barretos

Caxias do Sul

Curitiba

Itajaí

Lajeado

Londrina

Mogi das Cruzes

Porto Alegre

Porto Alegre, Rs

Rio de Janeiro

Santo André

São José do Rio Preto

São Paulo

Sorocaba

Plovdiv

Sofia

Toronto

Saint-Jérôme

Québec

Benešov nad Černou

Brno

Jindřichův Hradec

Kladno

Liberec

Nový Jičín

Olomouc

Pardubice

Prague

Tábor

Angers

Avignon

Dijon

Hyers

Le Mans

Paris

Rennes

Saint-Herblain

Valenciennes

Berlin

Brandenburg

Cologne

Dortmund

Dresden

Esslingen am Neckar

Gauting

Hamburg

Hanover

Herne

Kiel

Leipzig

Lübeck

Magdeburg

Merseburg

Minden

München

Paderborn

Recklinghausen

Weiden

Arkhangelsk

Chelyabinsk

Kursk

Moscow

Novosibirsk

Omsk

Saint Petersburg

Tomsk

Yaroslavi

Bournemouth

Cheltenham

Dundee

London

Manchester

Plymouth

Swindon